Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MicroStrategy Faces Dual Setbacks in Its Bitcoin Strategy

Robert Sasse by Robert Sasse
September 9, 2025
in Analysis, Bitcoin, Crypto Stocks, S&P 500, Tech & Software
0
Strategy Stock
0
SHARES
203
VIEWS
Share on FacebookShare on Twitter

The ambitious Bitcoin acquisition strategy pursued by software firm MicroStrategy has encountered significant challenges this week. The company experienced two substantial setbacks that raise questions about its future approach to cryptocurrency investment and corporate financing.

Exclusion From S&P 500 Index Delivers Blow

In a surprising market development, MicroStrategy failed to secure inclusion in the prestigious S&P 500 index despite meeting all technical qualifications. Instead, trading platform Robinhood received the coveted position, celebrating its inclusion with a 7 percent stock price surge following the announcement.

This exclusion represents more than just a symbolic disappointment for MicroStrategy. The company missed out on substantial automatic purchases by passive index funds that would have amounted to billions of dollars in investment. Investors responded negatively to the news, pushing the stock down by 3 percent in after-hours trading on Monday.

Continued Bitcoin Accumulation Amid Challenges

Despite this setback, Chairman Michael Saylor remains committed to his company’s substantial Bitcoin position. On September 8, MicroStrategy revealed the purchase of an additional 1,955 Bitcoin at a cost of $217 million. The acquisition price of $111,196 per coin demonstrates the company’s continued pattern of buying near market peaks.

With this latest purchase, MicroStrategy’s total holdings now reach 638,460 Bitcoin valued at over $71 billion—the largest corporate Bitcoin treasury globally. The company’s average purchase price stands at $73,880 per Bitcoin, generating substantial paper profits with the cryptocurrency currently trading around $112,000.

Should investors sell immediately? Or is it worth buying Strategy?

Investor Concerns Mount Over Strategy Shift

Recent performance metrics reveal growing investor skepticism. While Bitcoin itself has maintained relative strength, MicroStrategy shares have declined by 26 percent since July. The market capitalization-to-Bitcoin holdings ratio (mNAV) has contracted significantly to just 1.5 times the underlying cryptocurrency value.

More concerning to shareholders was the company’s recent policy reversal regarding equity issuance. In August, MicroStrategy abandoned its previous guideline against issuing new shares while the mNAV ratio remained below 2.5. This strategic U-turn creates potential dilution for existing shareholders and raises questions about the sustainability of the current Bitcoin accumulation approach.

Evaluating the Future Direction

MicroStrategy continues to serve as the primary Bitcoin proxy for traditional equity investors seeking cryptocurrency exposure. However, recent developments suggest the straightforward correlation between Bitcoin appreciation and MicroStrategy share performance has weakened considerably.

Market participants appear to be applying more rigorous scrutiny to the company’s capital allocation decisions rather than automatically rewarding additional Bitcoin purchases. The coming weeks will reveal whether MicroStrategy can maintain its premium valuation as a Bitcoin-focused equity or whether recent challenges signal a fundamental reassessment of its strategic direction.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Independent Bank Stock
Analysis

Independent Bank Shares Approach Peak Amid Insider Selling

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock
Analysis

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Next Post
iShares MSCI Global Gold Miners ETF Stock

Gold Mining Stocks Surge as Precious Metal Hits Record Highs

Nio Stock

Can Nio's Insurance Partnership Drive Its Stock Recovery?

Global X MSCI Argentina ETF Stock

Argentina's ETF Faces Unrelenting Decline Amid Political Turmoil

Recommended

NTSB Investigative Hearing Raises Concerns About Boeing 737 Max 9 Safety Practices

2 years ago
Immunovant Inc Stock

Immunovant’s Critical Juncture: All Eyes on September Catalyst

6 months ago
Plug Power Stock

Plug Power’s Contradiction: Operational Gains Versus Market Pessimism

6 months ago
Grayscale Bitcoin Stock

Bitcoin ETFs Face Mounting Pressure as Prices Plunge Below Key Threshold

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

Trending

Independent Bank Stock
Analysis

Independent Bank Shares Approach Peak Amid Insider Selling

by Rodolfo Hanigan
February 7, 2026
0

The stock of Independent Bank Corp. presents a notable market contradiction. Trading near its 52-week peak, the...

Communications Stock

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Hbt Financial Stock

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Independent Bank Shares Approach Peak Amid Insider Selling
  • The Race to Rewire: Fiber Optics Reshape the Telecom Landscape
  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com